Thermo Fisher Scientific Inc. (TMO)

Cash Flow Statement

Low level of difficulty

The cash flow statement provides information about a company’s cash receipts and cash payments during an accounting period, showing how these cash flaws link the ending cash balance to the beginning balance shown on the company’s balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Thermo Fisher Scientific Inc., consolidated cash flow statement

US$ in millions

	12 months ended	Dec 31, 2018		Dec 31, 2017		Dec 31, 2016		Dec 31, 2015		Dec 31, 2014
	Net income
	Loss from discontinued operations
	Income from continuing operations
	Depreciation and amortization
	Change in deferred income taxes
	Net gains on sale of businesses
	Non-cash stock-based compensation
	Tax benefits from stock-based compensation awards
	Other non-cash expenses, net
	Accounts receivable
	Inventories
	Other assets
	Accounts payable
	Other liabilities
	Contributions to retirement plans
	Changes in assets and liabilities, excluding the effects of acquisitions and dispositions
	Adjustments to reconcile income from continuing operations to net cash provided by operating activities
	Net cash provided by operating activities
	Acquisitions, net of cash acquired
	Proceeds from sale of businesses, net of cash divested
	Purchase of property, plant and equipment
	Proceeds from sale of property, plant and equipment
	(Increase) decrease in restricted cash
	Other investing activities, net
	Net cash used in investing activities
	Net proceeds from issuance of debt
	Repayment of debt
	Proceeds from issuance of commercial paper
	Repayments of commercial paper
	Increase in short-term notes payable
	Purchases of company common stock
	Dividends paid
	Net proceeds from issuance of company common stock
	Net proceeds from issuance of company common stock under employee stock plans
	Tax benefits from stock-based compensation awards
	Other financing activities, net
	Net cash provided by (used in) financing activities
	Net cash used in discontinued operating activities
	Net cash provided by (used in) discontinued operations
	Exchange rate effect on cash
	Increase (decrease) in cash, cash equivalents and restricted cash
	Cash, cash equivalents and restricted cash at beginning of period
	Cash, cash equivalents and restricted cash at end of period

Based on: 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-28), 10-K (filing date: 2017-02-28), 10-K (filing date: 2016-02-25), 10-K (filing date: 2015-02-26).

Cash flow statement item	Description	The company
Net cash provided by operating activities	Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.	Thermo Fisher Scientific Inc.’s net cash provided by operating activities increased from 2016 to 2017 and from 2017 to 2018.
Net cash used in investing activities	Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.	Thermo Fisher Scientific Inc.’s net cash used in investing activities declined from 2016 to 2017 but then increased from 2017 to 2018 exceeding 2016 level.
Net cash provided by (used in) financing activities	Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.	Thermo Fisher Scientific Inc.’s net cash provided by (used in) financing activities increased from 2016 to 2017 but then declined significantly from 2017 to 2018.

	Thermo Fisher Scientific Inc.	Other companies (not purchased previously)
Financial Statements
Common-Size Financial Statements
Analysis of Financial Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Long-term Trends
Analysis of Components of Financial Statements
Financial Reporting Quality

	All companies
Financial Statements
Common-Size Financial Statements
Analysis of Financial Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Long-term Trends
Analysis of Components of Financial Statements
Financial Reporting Quality